Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01724372

The Role of Antidepressants or Antipsychotics in Preventing Psychosis

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
St. Luke's-Roosevelt Hospital Center · Academic / Other
Sex
All
Age
12 Years – 25 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, controlled pilot study comparing the antidepressant fluoxetine with the second generation antipsychotic aripiprazole in approximately 10 subjects aged 12-25 at risk for developing psychosis. Our primary hypotheses are that compared to aripiprazole, fluoxetine will be better tolerated and will lead to greater improvement in symptoms at the end of 6 months of treatment.

Conditions

Interventions

TypeNameDescription
DRUGAntidepressant
DRUGAntipsychotic

Timeline

Start date
2012-10-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2012-11-09
Last updated
2014-05-26

Source: ClinicalTrials.gov record NCT01724372. Inclusion in this directory is not an endorsement.